North America dominated the global brain monitoring devices market, followed by Europe, Asia, and Rest of the World (RoW) in 2012. North America will continue to lead in the years to come, owing to technological advancements and introduction of advanced digitalized devices. European countries are expected to grow steadily, while the Asian region’s contribution to the global brain monitoring devices market is expected to pick pace in the next few years due to increasing awareness of neurological disorders, and development in Asian healthcare infrastructure, which has resulted in an influx of well-established players to the region.
Rising incidences of neurological disorders, autoimmune and cardiovascular diseases, brain disorders, and sleep disorders, rising awareness regarding neurodegenerative diseases and technological advancements in brain monitoring devices are major drivers slated to propel this market. However, the shortage of skilled technicians to handle these complex devices is a factor limiting the growth of this market.
The prominent players operating in this market include Covidien, PLC (Ireland), Compumedics, Ltd.(Australia), Natus Medical, Inc. (U.S.), Nihon Kohden Corporation (Japan), Integra Life Sciences Corporation (U.S.), CAS Medical Systems (U.S.), and Advanced Brain Monitoring, Inc. (U.S.), among others.
Buy a copy of this report at: http://www.marketsandmarkets.
Copyright©2012 Vocus, Inc.
All rights reserved